Evidence map›Paper›PMID 42404060›Full record

ArticleComputational and structural biotechnology journal2026

Minimum-Cost Synthetic Genome Planning: An Algorithmic Framework.

Michail Patsakis, Alexandros Margaris, Ioannis Mouratidis, Ilias Georgakopoulos-Soares

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michail PatsakisDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, Austin, TX, USA.
Alexandros MargarisDepartment of Computer Engineering, University of West Attica, Athens, Greece.ORCID https://orcid.org/0009-0002-8675-6820
Ioannis MouratidisDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, Austin, TX, USA.
Ilias Georgakopoulos-SoaresDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, Austin, TX, USA.ORCID https://orcid.org/0000-0003-3641-1488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As synthetic genomics scales toward the construction of increasingly larger genomes, computational strategies are needed to address technical feasibility. We introduce an algorithmic framework for the minimum-cost synthetic genome planning problem, aiming to identify the most cost-effective strategy to assemble a target genome from a source genome through a combination of reuse, synthesis, and join operations. By comparing dynamic programming and greedy heuristic strategies under diverse cost regimes, we demonstrate how algorithmic choices influence the cost efficiency of large-scale genome construction. In parallel, solving the minimum-cost synthetic genome planning problem can help us better understand genome architecture and evolution. Using both single closely related templates (e.g., bat coronavirus RaTG13) and diverse multisource consensus analyses, our results revealed that conserved regions such as ORF1ab can be reconstructed cost-effectively via sequence reuse. In contrast, highly variable regions such as the S (Spike) gene necessitate expensive

Identifiers

PMID42404060
PMCPMC13329036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.